NewEdge Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Sell |
1,605
-304
| -16% | -$78.4K | ﹤0.01% | 1811 |
|
|
2025
Q1 | $427K | Sell |
1,909
-219
| -10% | -$49K | ﹤0.01% | 1672 |
|
|
2024
Q4 | $487K | Sell |
2,128
-1,931
| -48% | -$442K | ﹤0.01% | 1578 |
|
|
2024
Q3 | $991K | Buy |
4,059
+2,365
| +140% | +$577K | 0.01% | 1118 |
|
|
2024
Q2 | $324K | Buy |
1,694
+1,549
| +1,068% | +$297K | ﹤0.01% | 1674 |
|
|
2024
Q1 | $28.7K | Buy |
145
+1
| +0.7% | +$198 | ﹤0.01% | 2495 |
|
|
2023
Q4 | $24.8K | Sell |
144
-100
| -41% | -$17.2K | ﹤0.01% | 2491 |
|
|
2023
Q3 | $36.1K | Buy |
244
+29
| +13% | +$4.29K | ﹤0.01% | 2194 |
|
|
2023
Q2 | $46.9K | Buy |
215
+83
| +63% | +$18.1K | ﹤0.01% | 2101 |
|
|
2023
Q1 | $29K | Sell |
132
-329
| -71% | -$72.2K | ﹤0.01% | 2214 |
|
|
2022
Q4 | $67.5K | Buy |
+461
| New | +$67.5K | ﹤0.01% | 1607 |
|
|
2022
Q1 | – | Sell |
-2,076
| Closed | -$541K | – | 1533 |
|
|
2021
Q4 | $541K | Buy |
+2,076
| New | +$541K | 0.01% | 1037 |
|
|
2021
Q1 | – | Sell |
-1,458
| Closed | -$310K | – | 1101 |
|
|
2020
Q4 | $310K | Sell |
1,458
-2,050
| -58% | -$436K | 0.01% | 752 |
|
|
2020
Q3 | $602K | Buy |
3,508
+614
| +21% | +$105K | 0.02% | 516 |
|
|
2020
Q2 | $556K | Buy |
2,894
+455
| +19% | +$87.4K | 0.02% | 505 |
|
|
2020
Q1 | $359K | Sell |
2,439
-1,436
| -37% | -$211K | 0.02% | 552 |
|
|
2019
Q4 | $600K | Buy |
3,875
+556
| +17% | +$86.1K | 0.02% | 473 |
|
|
2019
Q3 | $443K | Buy |
+3,319
| New | +$443K | 0.02% | 533 |
|